# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-17-070586
Filing Date
2017-03-06
Accepted
2017-03-06 08:01:05
Documents
23
Period of Report
2017-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d357746d8k.htm | 8-K | 16488
2 | EX-99.1 | d357746dex991.htm | EX-99.1 | 16916
3 | GRAPHIC | g357746ex99_1s10g1.jpg | GRAPHIC | 359286
4 | GRAPHIC | g357746ex99_1s11g1.jpg | GRAPHIC | 310927
5 | GRAPHIC | g357746ex99_1s12g1.jpg | GRAPHIC | 303764
6 | GRAPHIC | g357746ex99_1s13g1.jpg | GRAPHIC | 413169
7 | GRAPHIC | g357746ex99_1s14g1.jpg | GRAPHIC | 441982
8 | GRAPHIC | g357746ex99_1s15g1.jpg | GRAPHIC | 436947
9 | GRAPHIC | g357746ex99_1s16g1.jpg | GRAPHIC | 272644
10 | GRAPHIC | g357746ex99_1s17g1.jpg | GRAPHIC | 325530
11 | GRAPHIC | g357746ex99_1s18g1.jpg | GRAPHIC | 318625
12 | GRAPHIC | g357746ex99_1s19g1.jpg | GRAPHIC | 341312
13 | GRAPHIC | g357746ex99_1s1g1.jpg | GRAPHIC | 174118
14 | GRAPHIC | g357746ex99_1s20g1.jpg | GRAPHIC | 446598
15 | GRAPHIC | g357746ex99_1s21g1.jpg | GRAPHIC | 386272
16 | GRAPHIC | g357746ex99_1s2g1.jpg | GRAPHIC | 386272
17 | GRAPHIC | g357746ex99_1s3g1.jpg | GRAPHIC | 673362
18 | GRAPHIC | g357746ex99_1s4g1.jpg | GRAPHIC | 390607
19 | GRAPHIC | g357746ex99_1s5g1.jpg | GRAPHIC | 446401
20 | GRAPHIC | g357746ex99_1s6g1.jpg | GRAPHIC | 300537
21 | GRAPHIC | g357746ex99_1s7g1.jpg | GRAPHIC | 272736
22 | GRAPHIC | g357746ex99_1s8g1.jpg | GRAPHIC | 349992
23 | GRAPHIC | g357746ex99_1s9g1.jpg | GRAPHIC | 311960
| Complete submission text file | 0001193125-17-070586.txt |  | 10592085

Mailing Address 2910 SEVENTH ST BERKELEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14710 | Film No.: 17666503
SIC: 2834 Pharmaceutical Preparations